Characterization of the phase I metabolism of resibufogenin and evaluation of the metabolic effects on its antitumor activity and toxicity

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiotonic Steroids-Mediated Na+/K+-ATPase Targeting Could Circumvent Various Chemoresistance Pathways

  2013cited by this paper
• Isolation and identification of phase I metabolites of resibufogenin in rats

  2013cited by this paper
• A highly selective probe for human cytochrome P450 3A4: isoform selectivity, kinetic characterization and its applications.

  2013cited by this paper
• Resibufogenin Administration Prevents Oxidative Stress in a Rat Model of Human Preeclampsia

  2012cited by this paper
• Marinobufagenin Predicts and Resibufogenin Prevents Preeclampsia: A Review of the Evidence

  2012cited by this paper
• Simultaneous Determination of Resibufogenin and Its Major Metabolite 3-epi-Resibufogenin in Rat Plasma by HPLC Coupled with Tandem Mass Spectrometry

  2012cited by this paper
• Selective Mechanism-Based Inactivation of CYP3A4 by CYP3cide (PF-04981517) and Its Utility as an In Vitro Tool for Delineating the Relative Roles of CYP3A4 versus CYP3A5 in the Metabolism of Drugs

  2012cited by this paper
• Comparative Metabolism of Cinobufagin in Liver Microsomes from Mouse, Rat, Dog, Minipig, Monkey, and Human

  2011cited by this paper
• Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia.

  2011cited by this paper
• Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.

  2011cited by this paper
• Identification of cinobufagin metabolites in the bile of rats

  2010cited by this paper
• Marinobufagenin, resibufogenin and preeclampsia.

  2010cited by this paper
• Resibufogenin Prevents the Manifestations of Preeclampsia in an Animal Model of the Syndrome

  2010cited by this paper
• Preparative separation and purification of bufadienolides from Chinese traditional medicine of ChanSu using high-speed counter-current chromatography.

  2010cited by this paper
• Sudden death associated with intravenous injection of toad extract.

  2009cited by this paper
• Simultaneous Quantification of Seven Major Bufadienolides in Three Traditional Chinese Medicinal Preparations of ChanSu by HPLC-DAD

  2009cited by this paper
• Na+/K+-ATPase alpha subunits as new targets in anticancer therapy.

  2008cited by this paper
• Novel therapeutic applications of cardiac glycosides

  2008cited by this paper
• Cardiac glycosides as novel cancer therapeutic agents.

  2008cited by this paper
• Microbial transformation of cinobufagin by Syncephalastrum racemosum.

  2008cited by this paper
• The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers.

  2007cited by this paper
• Microbial transformation of three bufadienolides by Penicillium aurantigriseum and its application for metabolite identification in rat

  2007cited by this paper
• Cytochrome P450s and other enzymes in drug metabolism and toxicity

  2006cited by this paper
• Significance of the Minor Cytochrome P450 3A Isoforms

  2006cited by this paper
• Resibufogenin Corrects Hypertension in a Rat Model of Human Preeclampsia

  2006cited by this paper
• Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus.

  2005cited by this paper
• SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST

  2005influential reference
• New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

  2005cited by this paper
• The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective

  2003cited by this paper
• Toad venom poisoning: resemblance to digoxin toxicity and therapeutic implications

  2003cited by this paper
• Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism.

  2002influential reference
• Cardiac toxicity of resibufogenin: electrophysiological evidence.

  2001cited by this paper
• Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.

  2001cited by this paper
• Efficacy of digoxin specific Fab fragments (Digibind) in the treatment of toad venom poisoning.

  1999cited by this paper
• Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.

  1998cited by this paper
• Structure-cytotoxic activity relationship for the toad poison bufadienolides.

  1998cited by this paper
• Metabolism and disposition of kyushin, a drug containing senso (ch'an su).

  1996cited by this paper

• Characterization of CYP3A5 Selective Inhibitors for Reaction Phenotyping of Drug Candidates

  2024cites this paper
• Rationally Engineered CYP3A4 Fluorogenic Substrates for Functional Imaging Analysis and Drug-Drug Interaction Studies.

  2023cites this paper
• Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A.

  2022cites this paper
• Metabolic Characteristics of SM-1, a Novel PAC-1 Derivative, in Human Liver Microsomes

  2021cites this paper
• Molecular probes for human cytochrome P450 enzymes: Recent progress and future perspectives

  2021cites this paper
• Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation

  2020cites this paper
• Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism

  2020cites this paper
• Venenum bufonis: An overview of its traditional use, natural product chemistry, pharmacology, pharmacokinetics and toxicology.

  2019cites this paper
• Cytochrome P450 3A Enzymes Are Key Contributors for Hepatic Metabolism of Bufotalin, a Natural Constitute in Chinese Medicine Chansu

  2019cites this paper
• Application of highly efficient and lowly toxic bufadienolides screened from toad skin in lymphatic chemotherapy for colorectal cancer through a lymphatic metastatic model

  2019cites this paper
• Simultaneous determination of resibufogenin and its eight metabolites in rat plasma by LC-MS/MS for metabolic profiles and pharmacokinetic study.

  2019cites this paper
• Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis

  2018cites this paper
• Arenobufagin is a novel isoform-specific probe for sensing human sulfotransferase 2A1

  2018cites this paper
• 1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology

  2018cites this paper
• In vitro metabolism studies of natural products are crucial in the early development of medicines

  2017cites this paper
• In vitro phase I metabolism of gamabufotalin and arenobufagin: Reveal the effect of substituent group on metabolic stability.

  2017cites this paper
• The prenylated phenolic natural product isoglycycoumarin is a highly selective probe for human cytochrome P450 2A6

  2017cites this paper
• A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5.

  2017cites this paper
• Metabolic Profile of 3-Acetyl-11-Keto-β-Boswellic Acid and 11-Keto-β-Boswellic Acid in Human Preparations In Vitro, Species Differences, and Bioactivity Variation

  2016cites this paper
• Characterization of regio- and stereo-selective sulfation of bufadienolides: exploring the mechanism and providing insight into the structure–sulfation relationship by experimentation and molecular docking analysis

  2016cites this paper
• Interspecies variation in phase I metabolism of bufalin in hepatic microsomes from mouse, rat, dog, minipig, monkey, and human

  2015cites this paper
• A Mechanism-Based Model for the Prediction of the Metabolic Sites of Steroids Mediated by Cytochrome P450 3A4

  2015cites this paper
• Gomisin A is a Novel Isoform-Specific Probe for the Selective Sensing of Human Cytochrome P450 3A4 in Liver Microsomes and Living Cells

  2015cites this paper
• Structure-function relationships in intracellular and secreted pulmonary surfactant complexes: development and implementation of cellular models

  2015cites this paper